Haemonetics Corp (NYSE:HAE)
$ 83.51 -1.75 (-2.05%) Market Cap: 4.19 Bil Enterprise Value: 5.21 Bil PE Ratio: 34.65 PB Ratio: 4.79 GF Score: 76/100

Q3 2021 Haemonetics Corp Earnings Call Transcript

Feb 02, 2021 / 01:00PM GMT
Release Date Price: $129.93 (+12.98%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Haemonetics Corporation Q3 2021 Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference to your speaker today, Olga Guyette, Director, Investor Relations. Please go ahead, ma'am.

Olga Guyette
Haemonetics Corporation - Director of IR

Thank you. Good morning, everyone. Thank you for joining us for Haemonetics Third Quarter Fiscal '21 Conference Call and Webcast. I'm joined today by Chris Simon, our CEO; Stewart Strong, President of the Hospital business unit; and Bill Burke, our CFO. This morning, we posted our third quarter and year-to-date fiscal '21 results to our Investor Relations website, including the analytical tables with the information that we'll refer to on this call and an investor presentation on the pending Cardiva transaction. Additionally, we provided a complete P&L, balance sheet, summary statement of cash flows as well as reconciliations of our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot